Medicare to Withdraw Skin Substitute LCDs: Organogenesis and MiMedx Decline

viernes, 26 de diciembre de 2025, 10:43 am ET1 min de lectura
MDXG--
ORGO--

Medicare plans to withdraw Local Coverage Determinations (LCDs) for certain skin substitute products, affecting Organogenesis (ORGO) and MiMedx (MDXG), which traded lower on Friday. The withdrawal of LCDs, set to take effect next year, could impact the companies' revenue.

Medicare to Withdraw Skin Substitute LCDs: Organogenesis and MiMedx Decline

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios